|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Siegel RL and Jemal A: Lung
cancer statistics. Adv Exp Med Biol. 893:1–19. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hayat MJ, Howlader N, Reichman ME and
Edwards BK: Cancer statistics, trends, and multiple primary cancer
analyses from the surveillance, epidemiology, and end results
(SEER) program. Oncologist. 12:20–37. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lortet-Tieulent J, Soerjomataram I, Ferlay
J, Rutherford M, Weiderpass E and Bray F: International trends in
lung cancer incidence by histological subtype: Adenocarcinoma
stabilizing in men but still increasing in women. Lung Cancer.
84:13–22. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu FX, Su YL, Zhang H, Kong JY, Yu H and
Qian BY: Prognostic implications for high expression of miR-25 in
lung adenocarcinomas of female non-smokers. Asian Pac J Cancer
Prev. 15:1197–1203. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang L, Yang G, Zhou M, Smith M, Ge H,
Boreham J, Hu Y, Peto R, Wang J and Chen Z: Body mass index and
mortality from lung cancer in smokers and nonsmokers: A nationally
representative prospective study of 220,000 men in China. Int J
Cancer. 125:2136–2143. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: The impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mitra R, Sun J and Zhao Z: MicroRNA
regulation in cancer: One arm or two arms? Int J Cancer.
137:1516–1518. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Worley LA, Long MD, Onken MD and Harbour
JW: Micro-RNAs associated with metastasis in uveal melanoma
identified by multiplexed microarray profiling. Melanoma Res.
18:184–190. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Paul P, Chakraborty A, Sarkar D, Langthasa
M, Rahman M, Bari M, Singha RS, Malakar AK and Chakraborty S:
Interplay between miRNAs and human diseases. J Cell Physiol.
233:2007–2018. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Budhu A, Jia HL, Forgues M, Liu CG,
Goldstein D, Lam A, Zanetti KA, Ye QH, Qin LX, Croce CM, et al:
Identification of metastasis-related microRNAs in hepatocellular
carcinoma. Hepatology. 47:897–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang LP, Zhu ZT, Zhang Y and He CY:
Downregulation of microRNA-330 correlates with the radiation
sensitivity and prognosis of patients with brain metastasis from
lung cancer. Cell Physiol Biochem. 42:2220–2229. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dong J, Zhang Z, Gu T, Xu SF, Dong LX, Li
X, Fu BH and Fu ZZ: The role of microRNA-21 in predicting brain
metastases from non-small cell lung cancer. Onco Targets Ther.
10:185–194. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang XC, Wang W, Zhang ZB, Zhao J, Tan XG
and Luo JC: Overexpression of miRNA-21 promotes
radiation-resistance of non-small cell lung cancer. Radiat Oncol.
8:1462013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jiang LP, He CY and Zhu ZT: Role of
microRNA-21 in radiosensitivity in non-small cell lung cancer cells
by targeting PDCD4 gene. Oncotarget. 8:23675–23689. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Powrozek T, Krawczyk P, Kowalski DM,
Kuźnar-Kamińska B, Winiarczyk K, Olszyna-Serementa M,
Batura-Gabryel H and Milanowski J: Application of plasma
circulating microRNA-448, 506, 4316, and 4478 analysis for
non-invasive diagnosis of lung cancer. Tumour Biol. 37:2049–2055.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Matikas A, Syrigos KN and Agelaki S:
Circulating biomarkers in non-small-cell lung cancer: Current
status and future challenges. Clin Lung Cancer. 17:507–516. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li W, Wang Y, Zhang Q, Tang L, Liu X, Dai
Y, Xiao L, Huang S, Chen L, Guo Z, et al: MicroRNA-486 as a
biomarker for early diagnosis and recurrence of non-small cell lung
cancer. PLoS One. 10:e01342202015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Greystoke A, Ayub M, Rothwell DG, Morris
D, Burt D, Hodgkinson CL, Morrow CJ, Smith N, Aung K, Valle J, et
al: Development of a circulating miRNA assay to monitor tumor
burden: From mouse to man. Mol Oncol. 10:282–291. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y,
et al: Reduced expression of the let-7 microRNAs in human lung
cancers in association with shortened postoperative survival.
Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu T, Hu H, Zhang T, Jiang L, Li X, Liu S,
Zheng C, Yan G, Chen W, Ning Y, et al: MiR-25 promotes cell
proliferation, migration, ad invasion of non-small cell lung cancer
by targeting the LATS2/YAP signaling pathway. Oxid Med cell Longev.
18:97197232019.
|
|
26
|
Li Q, Zou C, Zou C, Han Z, Xiao H, Wei H,
Wang W, Zhang L, Zhang X, Tang Q, et al: MicroRNA-25 functions as a
potential tumor suppressor in colon cancer by targeting smad7.
Cancer Lett. 335:168–174. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen H, Pan H, Qian Y, Zhou W and Liu X:
miR-25-3p promotes the proliferation of triple negative breast
cancer by targeting BTG2. Mol Cancer. 17:42018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schmittgen TD, Lee EJ and Jiang J:
High-throughput real-time PCR. Methods Mol Biol. 429:89–98. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Funai K, Kawase A, Mizuno K, Koyama S and
Shiiya N: 8th edition tumor, node, and metastasis T-stage prognosis
discrepancies: Solid component diameter predicts prognosis better
than invasive component diameter. Cancer (Basel). 12:15772020.
View Article : Google Scholar
|
|
30
|
Rami-Porta R, Bolejack V, Crowley J, Ball
D, Kim J, Lyons G, Rice T, Suzuki K, Thomas CF Jr, Travis WD, et
al: The IASLC lung cancer staging project: Proposals for the
revisions of the T descriptors in the forthcoming eighth edition of
the TNM classification for lung cancer. J Thorac Oncol.
10:990–1003. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schiller JH, Harrington D, Belani CP,
Langer C, Sandler A, Krook J, Zhu J and Johnson DH; Eastern
Cooperative Oncology Group, : Comparison of four chemotherapy
regimens for advanced non-small-cell lung cancer. N Engl J Med.
346:92–98. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sandler A, Gray R, Perry MC, Brahmer J,
Schiller JH, Dowlati A, Lilenbaum R and Johnson DH:
Paclitaxel-Carboplatin alone or with bevacizumab for non-small-cell
lung cancer. N Engl J Med. 355:2542–2550. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lv J, Jiang QS, Song XJ, Wang CL, Guo LJ,
Wang SN, Li FS and Hu WW: Role of VEGF-A/C and CCR-7 in the
enhanced metastasis of A549 cells induced by 2 and 4 Gy X-rays in
vitro and in vivo. Sci China Tech Sci. 57:990–997. 2014. View Article : Google Scholar
|
|
34
|
Lv J, Wang SN, Song XJ, Li X, He R, Yu HJ,
Chen S, Wang L and Jiang QS: The impact of X-rays on the
expressions of miR-130a/miR-25 and its potential role in the
enhanced metastasis of A549 cell lines in vitro induced by X-rays.
Sci China Technol Sci. 56:2243–2249. 2013. View Article : Google Scholar
|
|
35
|
Doval DC, Deshpande R, Dhabhar B, Babu KG,
Prabhash K, Chopra R, Sripada PV, Deshmukh C and Suryavanshi M:
Liquid biopsy: A potential and promising diagnostic tool for
advanced stage non-small cell lung cancer patients. Indian J
Cancer. 54 (Suppl):S25–S30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Han Y and Li H: miRNAs as biomarkers and
for the early detection of non-small cell lung cancer (NSCLC). J
Thorac Dis. 10:3119–3131. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Geng Q, Fan T, Zhang B, Wang W, Xu Y and
Hu H: Five microRNAs in plasma as novel biomarkers for screening of
early-stage non-small cell lung cancer. Respir Res. 15:1492014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhou Y, Li R, Yu H, Wang R and Shen Z:
MicroRNA-130a is an oncomir suppressing the expression of CRMP4 in
gastric cancer. Onco Targets Ther. 10:3893–3905. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang K, Chen M and Wu W: Analysis of
microRNA (miRNA) expression profiles reveals 11 key biomarkers
associated with non-small cell lung cancer. World J Surg Oncol.
15:1752017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Daugaard I, Veno MT, Yan Y, Kjeldsen TE,
Lamy P, Hager H, Kjems J and Hansen LL: Small RNA sequencing
reveals metastasis-related microRNAs in lung adenocarcinoma.
Oncotarget. 8:27047–27061. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li Y, Li Y, Liu J, Fan Y, Li X, Dong M,
Liu H and Chen J: Expression levels of microRNA-145 and
microRNA-10b are associated with metastasis in non-small cell lung
cancer. Cancer Biol Ther. 17:272–279. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chabre O, Libe R, Assie G, Barreau O,
Bertherat J, Bertagna X, Feige JJ and Cherradi N: Serum miR-483-5p
and miR-195 are predictive of recurrence risk in adrenocortical
cancer patients. Endocr Relat Cancer. 20:579–594. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Acunzo M, Visone R, Romano G, Veronese A,
Lovat F, Palmieri D, Bottoni A, Garofalo M, Gasparini P, Condorelli
G, et al: miR-130a targets MET and induces TRAIL-sensitivity in
NSCLC by downregulating miR-221 and 222. Oncogene. 31:634–642.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xu X, Zhu S, Tao Z and Ye S: High
circulating miR-18a, miR-20a, and miR-92a expression correlates
with poor prognosis in patients with non-small cell lung cancer.
Cancer Med. 7:21–31. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Dacic S, Kelly L, Shuai Y and Nikiforova
MN: miRNA expression profiling of lung adenocarcinomas: Correlation
with mutational status. Mod Pathol. 23:1577–1582. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wu T, Chen W, Kong D, Li X, Lu H, Liu S,
Wang J, Du L, Kong Q, Huang X and Lu Z: miR-25 targets the
modulator of apoptosis 1 gene in lung cancer. Carcinogenesis.
36:925–935. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen Z, Wu Y, Meng Q and Xia Z: Elevated
microRNA-25 inhibits cell apoptosis in lung cancer by targeting
RGS3. In vitro cell. Dev Biol Anim. 52:62–67. 2016. View Article : Google Scholar
|
|
48
|
Deek MP, Kim S, Yue N, Baby R, Ahmed I,
Zou W, Langenfeld J, Aisner J and Jabbour SK: Modern radiotherapy
using image guidance for unresectable non-small cell lung cancer
can improve outcomes in patients treated with chemoradiation
therapy. J Thorac Dis. 8:2602–2609. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hartford AC, Gohongi T, Fukumura D and
Jain RK: Irradiation of a primary tumor, unlike surgical removal,
enhances angiogenesis suppression at a distal site: Potential role
of host-tumor interaction. Cancer Res. 60:2128–2131.
2000.PubMed/NCBI
|
|
50
|
Moncharmont C, Levy A, Guy JB, Falk AT,
Guilbert M, Trone JC, Alphonse G, Gilormini M, Ardail D, Toillon
RA, et al: Radiation-Enhanced cell migration/invasion process: A
review. Crit Rev Oncol Hematol. 92:133–142. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang H, Tan G, Dong L, Cheng L, Li K, Wang
Z and Luo H: Circulating miR-125b as a marker predicting
chemoresistance in breast cancer. PLoS One. 7:e342102012.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Farazi TA, Spitzer JI, Morozov P and
Tuschl T: miRNAs in human cancer. J Pathol. 223:102–115. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Manne U, Shanmugam C, Bovell L, Katkoori
VR and Bumpers HL: miRNAs as biomarkers for management of patients
with colorectal cancer. Biomark Med. 4:761–770. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Cha HJ, Shin S, Yoo H, Lee EM, Bae S, Yang
KH, Lee SJ, Park IC, Jin YW and An S: Identification of ionizing
radiation-responsive microRNAs in the IM9 human B lymphoblastic
cell line. Int J Oncol. 34:1661–1668. 2009.PubMed/NCBI
|
|
55
|
Baffa R, Fassan M, Volinia S, O'Hara B,
Liu CG, Palazzo JP, Gardiman M, Rugge M, Gomella LG, Croce CM and
Rosenberg A: MicroRNA expression profiling of human metastatic
cancers identifies cancer gene targets. J Pathol. 219:214–221.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Simone NL, Soule BP, Ly D, Saleh AD,
Savage JE, Degraff W, Cook J, Harris CC, Gius D and Mitchell JB:
Ionizing radiation-induced oxidative stress alters miRNA
expression. PLoS One. 4:e63772009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Li N, Fu H, Tie Y, Hu Z, Kong W, Wu Y and
Zheng X: miR-34a inhibits migration and invasion by down-regulation
of c-Met expression in human hepatocellular carcinoma cells. Cancer
Lett. 275:44–53. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Sayed D, Rane S, Lypowy J, He M, Chen LY,
Vashistha H, Yan L, Malhotra A, Vatner D and Abdellatif M:
MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol
Biol Cell. 19:3272–3282. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Valastyan S, Reinhardt F, Benaich N,
Calogrias D, Szász AM, Wang ZC, Brock JE, Richardson AL and
Weinberg RA: A pleiotropically acting microRNA, miR-31, inhibits
breast cancer metastasis. Cell. 137:1032–1046. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Valastyan S, Benaich N, Chang A, Reinhardt
F and Weinberg RA: Concomitant suppression of three target genes
can explain the impact of a microRNA on metastasis. Genes Dev.
23:2592–2597. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Chen Y and Gorski DH: Regulation of
angiogenesis through a microRNA (miR-130a) that down-regulates
antiangiogenic homeobox genes GAX and HOXA5. Blood. 111:1217–1226.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Yang X, Zhang Y, Hosaka K, Andersson P,
Wang J, Tholander F, Cao Z, Morikawa H, Tegnér J, Yang Y, et al:
VEGF-B promotes cancer metastasis through a VEGF-A-independent
mechanism and serves as a marker of poor prognosis for cancer
patients. Proc Natl Acad Sci USA. 112:E2900–E2909. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Jean C, Chen XL, Nam JO, Tancioni I, Uryu
S, Lawson C, Ward KK, Walsh CT, Miller NL, Ghassemian M, et al:
Inhibition of endothelial FAK activity prevents tumor metastasis by
enhancing barrier function. J Cell Biol. 204:247–263. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Ji RC: Lymph nodes and cancer metastasis:
New perspectives on the role of intranodal lymphatic sinuses. Int J
Mol Sci. 18:512016. View Article : Google Scholar
|
|
65
|
Liu Y, Wu BQ, Geng H, Xu ML and Zhong HH:
Association of chemokine and chemokine receptor expression with the
invasion and metastasis of lung carcinoma. Oncol Lett.
10:1315–1322. 2015. View Article : Google Scholar : PubMed/NCBI
|
